Thank you all for your generous replies. Agreed, I'm confident the Dr J and company are way ahead of this and is the reason they added the PD-L1 marker test to the protocol, not just as an affirmation of LL's ability to raise PD-L1 but as a potential new line of treatment as well.

I'm wondering when we would expect to get interim data?

Long and adding shares